The Journal of Nutritional Biochemistry
Volume 21, Issue 7 , Pages 580-588 , July 2010

l-Carnitine attenuates angiotensin II-induced proliferation of cardiac fibroblasts: role of NADPH oxidase inhibition and decreased sphingosine-1-phosphate generation

  • Hung-Hsin Chao

      Affiliations

    • Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan, ROC
    • Both Hung-Hsin Chao and Ju-Chi Liu equally contributed to this work.
    • ,
  • Cheng-Hsien Chen

      Affiliations

    • Department of Medicine, Taipei Medical University, Taipei, Taiwan, ROC
    • ,
  • Ju-Chi Liu

      Affiliations

    • Department of Medicine, Taipei Medical University, Taipei, Taiwan, ROC
    • Both Hung-Hsin Chao and Ju-Chi Liu equally contributed to this work.
    • ,
  • Jia-Wei Lin

      Affiliations

    • Department of Medicine, Taipei Medical University, Taipei, Taiwan, ROC
    • ,
  • Kar-Lok Wong

      Affiliations

    • Department of Anesthesiology, China Medical University Hospital, Taichung, Taiwan, ROC
    • ,
  • Tzu-Hurng Cheng

      Affiliations

    • Department of Biological Science and Technology, College of Life Sciences, China Medical University, Taichung, Taiwan, ROC
    • Corresponding Author InformationCorresponding author. Tel.: +886 931770381; fax: +886 27827654.

Received 3 November 2008 ,Revised 16 February 2009 ,Accepted 9 March 2009.

References 

  1. Rebouche CJ. Kinetics, pharmacokinetics, and regulation of l-carnitine and acetyl-l-carnitine metabolism. Ann N Y Acad Sci. 2004;1033:30–41
  2. Alvarez M, Malecot CO, Gannier F, Lignon JM. Antimony-induced cardiomyopathy in guinea-pig and protection by l-carnitine. Br J Pharmacol. 2005;144:17–27
  3. Vanella A, Russo A, Acquaviva R, Campisi A, Di Giacomo C, Sorrenti V, et al. L -propionyl-carnitine as superoxide scavenger, antioxidant, and DNA cleavage protector. Cell Biol Toxicol. 2000;16:99–104
  4. Iliceto S, Scrutinio D, Bruzzi P, D'Ambrosio G, Boni L, Di Biase M, et al. Effects of l-carnitine administration on left ventricular remodeling after acute anterior myocardial infarction: the l-Carnitine Ecocardiografia Digitalizzata Infarto Miocardico (CEDIM) Trial. J Am Coll Cardiol. 1995;26:380–387
  5. Schnee JM, Hsueh WA. Angiotensin II, adhesion, and cardiac fibrosis. Cardiovasc Res. 2000;46:264–268
  6. Zafari AM, Ushio-Fukai M, Akers M, Yin Q, Shah A, Harrison DG, et al. Role of NADH/NADPH oxidase-derived H2O2 in angiotensin II-induced vascular hypertrophy. Hypertension. 1998;32:488–495
  7. Cheng TH, Cheng PY, Shih NL, Chen IB, Wang DL, Chen JJ. Involvement of reactive oxygen species in angiotensin II-induced endothelin-1 gene expression in rat cardiac fibroblasts. J Am Coll Cardiol. 2003;42:1845–1854
  8. Pyne S, Pyne NJ. Sphingosine 1-phosphate signalling in mammalian cells. Biochem J. 2000;349:385–402
  9. Saba JD, Hla T. Point-counterpoint of sphingosine 1-phosphate metabolism. Circ Res. 2004;94:724–734
  10. Sivarajah A, Chatterjee PK, Patel NS, Todorovic Z, Hattori Y, Brown PA, et al. Agonists of peroxisome-proliferator activated receptor-gamma reduce renal ischemia/reperfusion injury. Am J Nephrol. 2003;23:267–276
  11. Zhang AY, Yi F, Jin S, Xia M, Chen QZ, Gulbins E, et al. Acid sphingomyelinase and its redox amplification in formation of lipid raft redox signaling platforms in endothelial cells. Antioxid Redox Signal. 2007;9:817–828
  12. Mulders AC, Hendriks-Balk MC, Mathy MJ, Michel MC, Alewijnse AE, Peters SL. Sphingosine kinase-dependent activation of endothelial nitric oxide synthase by angiotensin II. Arterioscler Thromb Vasc Biol. 2006;26:2043–2048
  13. Cowart LA, Wei S, Hsu MH, Johnson EF, Krishna MU, Falck JR, et al. The CYP4A isoforms hydroxylate epoxyeicosatrienoic acids to form high affinity peroxisome proliferator-activated receptor ligands. J Biol Chem. 2002;277:35105–35112
  14. Smith RS, Agata J, Xia CF, Chao L, Chao J. Human endothelial nitric oxide synthase gene delivery protects against cardiac remodeling and reduces oxidative stress after myocardial infarction. Life Sci. 2005;76:2457–2471
  15. Steen H, Kolmakova A, Stuber M, Rodriguez ER, Gao F, Chatterjee S, et al. MRI visualized neo-intimal dissection and co-localization of novel apoptotic markers apolipoprotein C-1, ceramide and caspase-3 in a Watanabe hyperlipidemic rabbit model. Atherosclerosis. 2007;191:82–89
  16. Garrelds IM, Elliott GR, Zijlstra FJ, Bonta IL. Effects of short- and long-term feeding of l-carnitine and congeners on the production of eicosanoids from rat peritoneal leucocytes. Br J Nutr. 1994;72:785–793
  17. Bueno R, Alvarez de Sotomayor M, Perez-Guerrero C, Gomez-Amores L, Vazquez CM, Herrera MD. l-carnitine and propionyl-l-carnitine improve endothelial dysfunction in spontaneously hypertensive rats: different participation of NO and COX-products. Life Sci. 2005;77:2082–2097
  18. Cipolla MJ, Nicoloff A, Rebello T, Amato A, Porter JM. Propionyl-l-carnitine dilates human subcutaneous arteries through an endothelium-dependent mechanism. J Vasc Surg. 1999;29:1097–1103
  19. Virag L, Kerekgyarto C, Fachet J. A simple, rapid and sensitive fluorimetric assay for the measurement of cell-mediated cytotoxicity. J Immunol Methods. 1995;185:199–208
  20. Cheng TH, Shih NL, Chen SY, Loh SH, Cheng PY, Tsai CS, et al. Reactive oxygen species mediate cyclic strain-induced endothelin-1 gene expression via Ras/Raf/extracellular signal-regulated kinase pathway in endothelial cells. J Mol Cell Cardiol. 2001;33:1805–1814
  21. Cheng TH, Shih NL, Chen SY, Wang DL, Chen JJ. Reactive oxygen species modulate endothelin-I-induced c-fos gene expression in cardiomyocytes. Cardiovasc Res. 1999;41:654–662
  22. Gyllenhammar H. Lucigenin chemiluminescence in the assessment of neutrophil superoxide production. J Immunol Methods. 1987;97:209–213
  23. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res. 1994;74:1141–1148
  24. Bass DA, Parce JW, Dechatelet LR, Szejda P, Seeds MC, Thomas M. Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J Immunol. 1983;130:1910–1917
  25. Edsall L, Vann L, Milstien S, Spiegel S. Enzymatic method for measurement of sphingosine 1-phosphate. Methods Enzymol. 2000;312:9–16
  26. Minter AJ, Keoshkerian E, Chesterman CN, Dawes J. Fibroblast growth factor and heparin protect endothelial cells from the effects of interleukin 1. J Cell Physiol. 1996;167:229–237
  27. Matsusaka T, Katori H, Homma T, Ichikawa I. Mechanism of cardiac fibrosis by angiotensin. New insight revealed by genetic engineering. Trends Cardiovasc Med. 1999;9:180–184
  28. Rosenkranz S. TGF-beta1 and angiotensin networking in cardiac remodeling. Cardiovasc Res. 2004;63:423–432
  29. Das DK, Maulik N, Engelman RM. Redox regulation of angiotensin II signaling in the heart. J Cell Mol Med. 2004;8:144–152
  30. Merrill AH, Schmelz EM, Dillehay DL, Spiegel S, Shayman JA, Schroeder JJ, et al. Sphingolipids–the enigmatic lipid class: biochemistry, physiology, and pathophysiology. Toxicol Appl Pharmacol. 1997;142:208–225
  31. Andrieu-Abadie N, Jaffrezou JP, Hatem S, Laurent G, Levade T, Mercadier JJ. l-carnitine prevents doxorubicin-induced apoptosis of cardiac myocytes: role of inhibition of ceramide generation. FASEB J. 1999;13:1501–1510
  32. Kitatani K, Idkowiak-Baldys J, Hannun YA. The sphingolipid salvage pathway in ceramide metabolism and signaling. Cell Signal. 2008;20:1010–1018
  33. Cheng CP, Ukai T, Onishi K, Ohte N, Suzuki M, Zhang ZS, et al. The role of ANG II and endothelin-1 in exercise-induced diastolic dysfunction in heart failure. Am J Physiol Heart Circ Physiol. 2001;280:H1853–H1860
  34. Brown JD, Plutzky J. Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets. Circulation. 2007;115:518–533
  35. Diep QN, Amiri F, Touyz RM, Cohn JS, Endemann D, Neves MF, et al. PPARalpha activator effects on Ang II-induced vascular oxidative stress and inflammation. Hypertension. 2002;40:866–871
  36. Girnun GD, Domann FE, Moore SA, Robbins ME. Identification of a functional peroxisome proliferator-activated receptor response element in the rat catalase promoter. Mol Endocrinol. 2002;16:2793–2801
  37. Baranowski M, Blachnio A, Zabielski P, Gorski J. PPARalpha agonist induces the accumulation of ceramide in the heart of rats fed high-fat diet. J Physiol Pharmacol. 2007;58:57–72

☆ Funding: This work was supported by the China Medical University (CMU-97-212), Taichung, and Shin Kong Wu Ho-Su Memorial Hospital (SKH-TMU-97-03), Taipei, Taiwan, R.O.C.

PII: S0955-2863(09)00060-6

doi: 10.1016/j.jnutbio.2009.03.003

The Journal of Nutritional Biochemistry
Volume 21, Issue 7 , Pages 580-588 , July 2010

Article Tools

* Image Usage & Resolution